Join the BioNap Email List:

Monday, August 10, 2015

Why I Think InVivo Shares Could Double

By Jason Napodano, CFA

- InVivo's financial position is solid, with existing cash to fund operations for another 16 months and access to another 3-4 years worth through its ATM.

- The clinical data being generated by the company's pilot study has been outstanding. I believe the company is revolutionizing how surgeons will treat spinal cord injury.

- I have built a detailed financial model that yields a stock price nearly double what the shares are trading for today.

Please read the article on Seeking-Alpha: LINK

No comments:

Post a Comment